Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
On this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. ...
7 Elo 201832min
Regina Barzilay, AI Small Molecule Discovery and Synthesis
On this episode, I speak with Regina Barzilay of MIT's Machine Learning for Pharmaceutical Discovery and Synthesis consortium ( http://mlpds.mit.edu ). Regina is a prolific researcher with many highly...
30 Heinä 201828min
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
On this episode, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases. They claim their approach can bring new treatments to patients 80% fa...
26 Heinä 201837min
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
On this episode, I speak with John Cassidy, CEO of Cambridge Cancer Genomics ( www.ccg.ai ). CCG aims to transform oncology by combining liquid biopsy with genomics and artificial intelligence to pred...
18 Heinä 201824min
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
On this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the dise...
10 Heinä 201825min
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
On this episode, I speak with Sam Cooper, cofounder and CEO of Phenomic AI ( www.phenomic.ai ). Sam and his team use machine learning for automated image analysis to study cell biology and screen drug...
28 Kesä 201823min
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
On this episode, I speak with Shai Shen-Orr, cofounder and chief scientist of CytoReason ( www.cytoreason.com ). CytoReason has created a machine learning model of the immune system. This model can in...
20 Kesä 201831min
